What is MOTS-c?
MOTS-c — short for mitochondrial open reading frame of the 12S rRNA-c — is a 16-amino-acid peptide encoded not in the cell's nuclear DNA but within a short open reading frame of the mitochondrial 12S rRNA gene. It belongs to a small, distinctive class called mitochondrial-derived peptides (MDPs), which also includes humanin. Its 2015 identification is often described as evidence that mitochondria are not only metabolic organelles but also a signaling unit with their own genetically encoded messengers.
What makes MOTS-c unusual is the direction of its signal: research characterizes it as a retrograde peptide that can move from the mitochondria to the nucleus under metabolic stress and influence the expression of stress-adaptation genes. Throughout this guide, MOTS-c is discussed strictly as a laboratory research peptide — it is not a medicine, and nothing here describes human or animal use.
The essentials at a glance
Mitochondrial-derived
A 16-amino-acid peptide encoded within the mitochondrial 12S rRNA gene — not the nuclear genome.
Folate–AMPK pathway
Research links its cellular actions to the folate cycle and activation of AMPK, a central energy sensor.
Retrograde signal
Characterized as moving from mitochondria to the nucleus under metabolic stress to shape gene expression.
99%+ verified purity
HPLC-verified and confirmed by LC-MS, with a batch-specific certificate of analysis — research use only.
Work with research-grade MOTS-c
A mitochondrial-derived peptide, HPLC-verified to 99%+ purity, with a batch-specific certificate of analysis in every order — for laboratory research use only.
View MOTS-cHow MOTS-c works: the folate–AMPK mechanism
The mechanism researchers most often describe centers on cellular energy sensing. In the foundational study, MOTS-c was reported to act through the folate cycle and its tethered de novo purine biosynthesis, leading to activation of AMP-activated protein kinase (AMPK) — a master regulator of cellular energy balance:
- Skeletal muscle as primary target — the original work identified skeletal muscle as MOTS-c's main studied organ, where it was associated with enhanced glucose metabolism.
- Folate cycle & AMPK — MOTS-c was reported to inhibit the folate cycle, altering purine biosynthesis intermediates and activating AMPK, a recurring theme across subsequent reviews.
- Retrograde, stress-responsive signaling — later research characterized MOTS-c as translocating to the nucleus under metabolic stress, where it is associated with the regulation of antioxidant-response and stress-adaptation genes.
In its foundational characterization, MOTS-c treatment was reported to prevent age-dependent and high-fat-diet-induced insulin resistance, as well as diet-induced obesity, in mouse models — findings that framed the peptide as a possible link between the mitochondrial genome and whole-organism metabolic regulation.
MOTS-c, exercise & aging
A distinctive strand of MOTS-c research connects it to physical activity and the biology of aging. In a widely cited 2021 study, MOTS-c was described as an exercise-induced mitochondrial-encoded factor:
- Exercise induction — the study reported that exercise increases endogenous MOTS-c expression in skeletal muscle and in circulation in humans.
- Physical capacity in mice — intermittent MOTS-c treatment was reported to enhance physical performance in young, middle-aged, and old mice, including when initiated late in life.
- Declining levels with age — reviews note that circulating MOTS-c levels have been reported to decrease with age, prompting research interest in its role in metabolic and age-related biology.
Beyond metabolism and aging, exploratory research has examined MOTS-c in other contexts — for instance, models of gestational glucose regulation and, separately, cell and animal studies probing its behavior in disease biology. These remain early-stage findings in controlled research settings, not clinical conclusions.
Where MOTS-c fits: the mitochondrial-derived peptides
MOTS-c is best understood alongside the other peptides encoded within the mitochondrial genome and the broader family of research peptides studied for mitochondrial and metabolic biology:
| Peptide | Origin | Studied for |
|---|---|---|
| MOTS-c | Mitochondrial 12S rRNA ORF | Glucose metabolism, AMPK, exercise, aging |
| Humanin | Mitochondrial 16S rRNA ORF | Cytoprotection and metabolic signaling |
| SS-31 (elamipretide) | Synthetic tetrapeptide | Mitochondrial membrane / cardiolipin research |
| NAD+ precursors | Nuclear-pathway cofactors | Sirtuin and energy-metabolism research |
Researchers studying mitochondrial and longevity biology often reference these tools together. For a related mechanism, see the guide on NAD+ and its role in energy metabolism; Peptora also carries NAD+ as a research compound, each with its own batch-specific certificate of analysis.
What the research explores
In laboratory settings, MOTS-c is most often studied across a handful of interconnected areas:
- Glucose metabolism & insulin sensitivity — how MOTS-c influences glucose handling in skeletal muscle in cell and rodent models.
- AMPK & energy sensing — the folate-cycle-to-AMPK axis proposed as its central mechanism.
- Exercise physiology — its induction by exercise and association with physical capacity in animal models.
- Aging & mitochondrial signaling — its behavior as an age-associated, stress-responsive retrograde signal.
These are descriptions of published findings, largely preclinical — they are not efficacy claims, and nothing here describes or endorses use outside controlled research.
Purity, testing & certificates of analysis
In research, the reliability of a result depends on the identity and purity of the material behind it. Every batch of MOTS-c from Peptora is HPLC-verified to 99%+ purity, confirmed by LC-MS identity testing, and screened across a full quality-control panel before release. Each order ships with a lot-specific certificate of analysis (COA) so the material can be matched to its documentation.
Researchers often choose Peptora precisely because this documentation is standard rather than optional. To understand what each figure on a report means, see the guide on purity and certificates of analysis and the overview of testing standards.
Handling MOTS-c in the laboratory
MOTS-c is supplied as a lyophilized (freeze-dried) powder. Before research use it is reconstituted with bacteriostatic water, which is sold separately. Careful handling preserves peptide integrity and the validity of downstream work:
- 1Allow the sealed vial to reach room temperature before opening.
- 2Add bacteriostatic water slowly against the vial wall; swirl gently and do not shake.
- 3Let the powder dissolve fully before drawing.
- 4Store the reconstituted solution refrigerated and protected from light.
Full step-by-step protocols live in the reconstitution guide and the storage guide. Following them consistently is one of the simplest ways to keep research reproducible.
Scientific references
The literature below is provided for educational context, per PubMed, and describes discovery, mechanistic, and preclinical research on MOTS-c — not the laboratory research product supplied by Peptora. It is a summary of published findings, not clinical guidance.
- 1Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21(3):443-454. doi:10.1016/j.cmet.2015.02.009 (PMID: 25738459).
- 2Reynolds JC, Lai RW, Woodhead JST, et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nat Commun. 2021;12(1):470. doi:10.1038/s41467-020-20790-0 (PMID: 33473109).
- 3Lee C, Kim KH, Cohen P. MOTS-c: A novel mitochondrial-derived peptide regulating muscle and fat metabolism. Free Radic Biol Med. 2016;100:182-187. doi:10.1016/j.freeradbiomed.2016.05.015 (PMID: 27216708).
- 4Wan W, Zhang L, Lin Y, et al. Mitochondria-derived peptide MOTS-c: effects and mechanisms related to stress, metabolism and aging. J Transl Med. 2023;21(1):36. doi:10.1186/s12967-023-03885-2 (PMID: 36670507).
- 5Zheng Y, Wei Z, Wang T. MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation. Front Endocrinol (Lausanne). 2023;14:1120533. doi:10.3389/fendo.2023.1120533 (PMID: 36761202).
- 6Yin Y, Pan Y, He J, et al. The mitochondrial-derived peptide MOTS-c relieves hyperglycemia and insulin resistance in gestational diabetes mellitus. Pharmacol Res. 2021;175:105987. doi:10.1016/j.phrs.2021.105987 (PMID: 34798268).
Explore research-grade MOTS-c
HPLC-verified to 99%+ purity, batch-specific COA, fast U.S. shipping — for laboratory research use only.
View MOTS-cKey takeaways
- MOTS-c is a 16-amino-acid mitochondrial-derived peptide encoded within a short open reading frame of the mitochondrial 12S rRNA gene — one of the small class of peptides written in the mitochondrial genome.
- Research characterizes it as a retrograde signal that can translocate to the nucleus under metabolic stress, acting largely through the folate cycle and activation of the energy sensor AMPK.
- Its primary studied target is skeletal muscle, where it is associated with enhanced glucose metabolism; in its foundational study it was reported to reduce insulin resistance and diet-induced obesity in mice.
- A separate line of research characterizes MOTS-c as exercise-induced and associated with physical capacity in aging mouse models, with circulating levels reported to decline with age.
- MOTS-c is a laboratory research compound only; the underlying literature is largely preclinical and makes no efficacy claims for human use.
- Peptora's MOTS-c is a lyophilized powder, HPLC-verified to 99%+ purity with a lot-specific certificate of analysis, reconstituted with bacteriostatic water before research use.
Frequently asked questions
This article is intended solely as an educational summary of publicly available scientific literature. Products offered by Peptora are supplied exclusively for laboratory research purposes and are not approved for human or veterinary use. The information presented should not be interpreted as medical advice, treatment recommendations, or clinical guidance.
